MENU
+Compare
SLRN
Stock ticker:
AS OF
May 20 closing price
Price
$2.27
Change
+$0.04 (+1.79%)
Capitalization
229.16M

SLRN ACELYRIN Forecast, Technical & Fundamental Analysis

Acelyrin Inc is a late-stage clinical biopharmaceutical company... Show more

SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SLRN with price predictions
Jun 27, 2025

Aroon Indicator for SLRN shows an upward move is likely

SLRN's Aroon Indicator triggered a bullish signal on June 25, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 57 similar instances where the Aroon Indicator showed a similar pattern. In of the 57 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 28, 2025. You may want to consider a long position or call options on SLRN as a result. In of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SLRN just turned positive on May 27, 2025. Looking at past instances where SLRN's MACD turned positive, the stock continued to rise in of 15 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 20 cases where SLRN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.563) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). SLRN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SLRN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SLRN is expected to report earnings to rise 23.30% to -126 cents per share on June 12

ACELYRIN SLRN Stock Earnings Reports
Q1'25
Est.
$-1.27
Q4'24
Beat
by $0.38
Q3'24
Beat
by $0.70
Q2'24
Beat
by $0.22
Q1'24
Beat
by $0.65
The last earnings report on March 27 showed earnings per share of -102 cents, beating the estimate of -140 cents. With 4.08M shares outstanding, the current market capitalization sits at 229.16M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4149 Liberty Canyon Road
Phone
+1 805 730-0360
Employees
130
Web
https://www.acelyrin.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY614.913.04
+0.50%
SPDR® S&P 500® ETF
BTC.X107327.700000239.273440
+0.22%
Bitcoin cryptocurrency
AAPL201.00N/A
N/A
Apple
TSLA323.63-2.15
-0.66%
Tesla
GME23.59-0.29
-1.21%
GameStop Corp

SLRN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRN has been loosely correlated with CMND. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SLRN jumps, then CMND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRN
1D Price
Change %
SLRN100%
N/A
CMND - SLRN
38%
Loosely correlated
+0.84%
THAR - SLRN
36%
Loosely correlated
+2.41%
CGEM - SLRN
36%
Loosely correlated
+0.13%
IDYA - SLRN
35%
Loosely correlated
-4.13%
STOK - SLRN
34%
Loosely correlated
-1.77%
More